Holen Sie sich die Stockscreener-App
88.15
1.01%
-0.90
Vorhandelsmarkt:
87.90
-0.25
-0.28%
Schlusskurs vom Vortag:
$89.05
Offen:
$90.21
24-Stunden-Volumen:
885.32K
Relative Volume:
0.67
Marktkapitalisierung:
$7.69B
Einnahmen:
Nettoeinkommen (Verlust:
$-386.19M
KGV:
-16.78
EPS:
-5.2547
Netto-Cashflow:
$-206.27M
1W Leistung:
-3.90%
1M Leistung:
-25.70%
6M Leistung:
-30.12%
1J Leistung:
-5.99%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$84.11
$93.67
52-Wochen-Spanne:
$69.81
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
88.15 | 7.69B | 0 | -386.19M | -206.27M | -5.2547 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-01 | Hochstufung | Jefferies | Hold → Buy |
| 2026-06-02 | Herabstufung | Jefferies | Buy → Hold |
| 2026-06-02 | Hochstufung | Wedbush | Underperform → Neutral |
| 2026-03-16 | Eingeleitet | Jefferies | Buy |
| 2026-02-24 | Eingeleitet | Wedbush | Outperform |
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-11-06 | Eingeleitet | Wolfe Research | Outperform |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-07-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-12-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-29 | Eingeleitet | Laidlaw | Buy |
| 2024-05-20 | Eingeleitet | BTIG Research | Buy |
| 2024-04-29 | Eingeleitet | Guggenheim | Buy |
| 2024-04-29 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-14 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-14 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Abivax Adr Aktie (ABVX) Neueste Nachrichten
ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the GapDownward Estimate Revision - careplusvn.com
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressLow Growth Earnings - dars.gov.et
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressEBITDA Estimate Trend - dars.gov.et
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressRevenue Breakdown Analysis - dars.gov.et
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why - Yahoo Finance
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsBreadth Thrust - siam.in
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsWeekly Profile - careplusvn.com
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsLate Stage Breakouts - dars.gov.et
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight - GlobeNewswire Inc.
Readystate Asset Management LP Raises Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Velan Capital Investment Management LP Sells 11,370 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Stock Holdings Increased by Seven Fleet Capital Management LP - MarketBeat
Abivax (ABVX) Quarterly Scorecard: Profit Per Share Falls Below Its Benchmark in the Reported Period - dars.gov.et
Abivax (ABVX) EPS and Revenue: EPS Misses Its Estimate in the Current Update; After Earnings: The Stock Loses 2.75% in Latest TradingEPS Surprise History - careplusvn.com
Abivax (ABVX) EPS and Revenue: EPS Misses Its Estimate in the Current Update; After Earnings: The Stock Loses 2.75% in Latest TradingEarnings Sentiment Score - dars.gov.et
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction: Shares Move Higher 1.36% in the Latest SessionEarnings Quality Score - dars.gov.et
Abivax SA Sponsored ADR $ABVX Shares Sold by Royal Bank of Canada - MarketBeat
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction: Shares Move Higher 1.36% in the Latest SessionProduct Revenue Analysis - careplusvn.com
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction - dars.gov.et
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordIPO Entry Watch - careplusvn.com
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordLast Point Support - dars.gov.et
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordMoney Flow Index - dars.gov.et
Abivax (ABVX): TCG Crossover and Chen Yu report 7.0% ADS stake - Stock Titan
Abivax S.A. (ABVX) investors report 6.0% beneficial stake via Invus entities - Stock Titan
ABIVAX (NASDAQ:ABVX) Flashes Strong Technical Rating and Breakout Setup - ChartMill
Bank of America Corp DE Purchases 213,440 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Militia Capital Management LLC Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Perceptive Advisors LLC Cuts Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Seven Fleet Capital Management LP Has $4.79 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Recommendation of "Moderate Buy" by Analysts - marketbeat.com
Avidity Partners Management LP Takes $1.11 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Vivo Capital LLC - MarketBeat
ABVX Q4 2025 Earnings: Wider-than-Expected Net Loss, Shares Still Climb 4.62%Earnings Quality Score - www.dars.gov.et
Stempoint Capital LP Has $34.94 Million Stock Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR Revenue Breakdown – FWB:2X10 - TradingView
Ally Bridge Group NY LLC Lowers Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Eversept Partners LP Has $104.05 Million Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Octagon Capital Advisors LP - MarketBeat
Orbimed Advisors LLC Has $51.86 Million Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Hsbc Holdings PLC Has $1.71 Million Stock Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Caxton Associates LLP Acquires Shares of 24,750 Abivax SA Sponsored ADR $ABVX - MarketBeat
Affinity Asset Advisors LLC Has $45.10 Million Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR Revenue Breakdown – SWB:2X10 - TradingView
Abivax SA Sponsored ADR $ABVX Position Increased by PSquared Asset Management AG - MarketBeat
Atika Capital Management LLC Sells 26,200 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
ABIVAX Société Anonyme (ABVX) stock price, news, quote and history - Yahoo Finance UK
ABIVAX Société Anonyme (ABVX) Stock Price, News, Quote & History - Yahoo! Finance Canada
ABIVAX Société Anonyme (ABVX) stock price, news, quote and history - Yahoo Finance Singapore
17,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Militia Capital Management LLC - MarketBeat
ETFs Investing in Abivax SA Sponsored ADR Stocks - TradingView
Finanzdaten der Abivax Adr-Aktie (ABVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Abivax Adr-Aktie (ABVX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sofinnova Crossover I SLP | Affiliate |
Oct 28 '25 |
Proposed Sale |
92.75 |
1,200,000 |
111,300,000 |
0 |
4.57%
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):